Cardiovascular actions of a new metabolite of propranolol: isopropylamine.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003714:Denervation; D004155:Diphenhydramine / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005730:Ganglionic Blockers / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006614:Hindlimb / Q000098:blood supply / Q000294:innervation; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D011433:Propranolol / Q000378:metabolism* / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012110:Reserpine / Q000494:pharmacology; D012601:Scopolamine / Q000494:pharmacology; D013268:Stimulation, Chemical; D014439:Tyramine / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D011437:Propylamines; D001285:Atropine; D012110:Reserpine; D004155:Diphenhydramine; D011433:Propranolol; D012601:Scopolamine; D009638:Norepinephrine; D014439:Tyramine